References
- Assmann, T.S., et al., 2018. MicroRNAs and diabetic kidney disease: systematic review and bioinformatic analysis. Molecular and cellular endocrinology, 477, 90–102.
- Bălăşescu, E., et al., 2016. Immunohistochemical aspects of cell death in diabetic nephropathy. Romanian journal of internal medicine, 54 (1), 54–62.
- Cai, J., et al., 2013. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. The journal of clinical investigation, 123 (2), 566–579.
- Campbell, L.M., Maxwell, P.J., and Waugh, D.J.J., 2013. Rationale and means to target pro-inflammatory interleukin-8 (CXCL8) signaling in cancer. Pharmaceuticals, 6 (8), 929–959.
- Chan, L.P., et al., 2017. IL-8 promotes inflammatory mediators and stimulates activation of p38 MAPK/ERK-NF-κB pathway and reduction of JNK in HNSCC. Oncotarget, 8 (34), 56375–56388.
- Cui, S., et al., 2017. CXCL8 antagonist improves diabetic nephropathy in male mice with diabetes and attenuates high glucose-induced mesangial injury. Endocrinology, 158 (6), 1671–1684.
- Gao, S.M., et al., 2011. MiR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level. Journal of experimental & clinical cancer research, 30 (1), 110.
- Huang, Z., et al., 2018. The enhancer RNA lnc-SLC4A1-1 epigenetically regulates unexplained recurrent pregnancy loss (URPL) by activating CXCL8 and NF-kB pathway. EBioMedicine, 38, 162–170.
- Kato, M. and Natarajan, R., 2015. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets. Annals of the New York Academy of Sciences, 1353, 72–88.
- Kumar, D., Robertson, S., and Burns, K.D., 2004. Evidence of apoptosis in human diabetic kidney. Molecular and cellular biochemistry, 259 (1–2), 67–70.
- Li, H., et al., 2017. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway. Biomedicine & pharmacotherapy, 96, 471–479.
- Li, M.Q., et al., 2012. CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway. Human reproduction, 27 (7), 2107–2116.
- Li, R., et al., 2014. MicroRNAs in diabetic kidney disease. International journal of endocrinology, 2014 (10), 593956.
- Pichler, R., et al., 2016. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. American journal of physiology renal physiology, 312 (4), F716–F731.
- Qian, X., et al., 2018. MicroRNA-134-5p promotes high glucose-induced podocyte apoptosis by targeting bcl-2. American journal of translational research, 10 (3), 989–997.
- Reidy, K., et al., 2014. Molecular mechanisms of diabetic kidney disease. Journal of clinical investigation, 124 (6), 2333–2340.
- Runtsch, M.C., et al., 2019. Anti-inflammatory microRNA-146a protects mice from diet-induced metabolic disease. PLoS genetics, 15 (2), e1007970.
- Shi, Y. and Hu, F.B., 2014. The global implications of diabetes and cancer. Lancet, 383 (9933), 1947–1948.
- Shinji, H., et al., 2006. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 21 (3), 605.
- Signs, S.A., et al., 2018. Stromal miR-20a controls paracrine CXCL8 secretion in colitis and colon cancer. Oncotarget, 9 (16), 13048–13059.
- Simpson, K., et al., 2016. MicroRNAs in diabetic nephropathy: from biomarkers to therapy. Current diabetes reports, 16 (3), 1–7.
- Song, G., et al., 2018. Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice. Journal of international medical research, 46 (7), 2883–2897.
- Sun, Y., et al., 2015. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. Journal of receptor and signal transduction research, 35 (6), 600–604.
- Taneda, S., et al., 2010. Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. American journal of physiology renal physiology, 299 (6), 1451–1461.
- Wang, X., et al., 2017. MicroRNA-20b contributes to high glucose-induced podocyte apoptosis by targeting SIRT7. Molecular medicine reports, 16 (4), 5667–5674.
- Waugh, D.J. and Wilson, C., 2008. The interleukin-8 pathway in cancer. Clinical cancer research: an official journal of the American Association for Cancer Research, 14 (21), 6735–6741.
- Yao, T., et al., 2018. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4. Journal of cellular physiology, 234 (1), 871–879.
- Ye, D., et al., 2018. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients. Life sciences., 208, 201–207.
- Yoshimura, T., et al., 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proceedings of the National Academy of Sciences of the United States of America, 84 (24), 9233–9237.
- You-Jie, L.I., et al., 2010. Inhibition of 293T cell proliferation by blocking miR-20 and miR-106 expression with antisense RNA. Chinese journal of pathophysiology, 26 (9), 1665–1669.
- Zhang, J.L., et al., 2013. Gabapentin reduces allodynia and hyperalgesia in painful diabetic neuropathy rats by decreasing expression level of Nav1.7 and p-ERK1/2 in DRG neurons. Brain research, 1493 (1), 13–18.
- Zhao, B., et al., 2016. MicroRNA-23b targets Ras GTPase-activating protein SH3 domain-binding protein 2 to alleviate fibrosis and albuminuria in diabetic nephropathy. Journal of the American Society of Nephrology, 27 (9), 2597–2608.
- Zhong, X., et al., 2013. MiR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia, 56 (3), 663–674.